- Intellipharmaceutics International (TSX:IPCI:CA) Tuesday announced that it applied for and received conditional approval to list the company’s common shares for trading on the TSX Venture Exchange.
- Upon listing on the TSXV, the company expects its shares to continue to trade under the symbol “IPCI”.
- The shares would also continue to be listed on the OTCQB Marketplace in the United States under the symbol “IPCIF”.
- Source: Press Release
Trending
- ‘I want to die “young” as late as possible,’ says 83-year-old triathlete doctor who reinvented himself after a midlife crisis
- 10 Israeli Soldiers Hospitalized After Wasp Swarm Attack
- Construction Partners posts strong Q2 amid high demand By Investing.com
- ZIM Integrated sails to top industrial gainer of week, Builders FirstSource sees loser tag
- US Marine Says 40% of Drones the IDF Has Shot Down Were Their Own
- Amprius Technologies doubles customer base, boosts revenue By Investing.com
- My 19-year-old son wants to get married so Uncle Sam will ‘kick in more scratch’ for his girlfriend’s financial aid. Is this a terrible idea?
- Meet the Doomsayers Waiting for the Economy to Crash
Sunday, July 27
Intellipharmaceutics receives conditional approval to list on the TSX Venture Exchange
By 
